Literature DB >> 10442560

Correlation of survival time with size of axonal swellings in diffuse axonal injury.

A E Wilkinson1, L R Bridges, S Sivaloganathan.   

Abstract

Widespread damage to axons in the white matter of the brain is a well-recognised consequence of non-missile head injury. This diffuse axonal injury is characterised by a gradual swelling of the axon associated with an accumulation of cellular organelles and proteins. We have investigated the relationship between the size of the swellings of the damaged axon with survival time in post-mortem brain tissue. Sixty-six cases of head injury with known length of post-traumatic survival were selected for study, and immunohistochemistry for beta-amyloid precursor protein (betaAPP) was carried out. The minimum diameter of the betaAPP-immunolabelled damaged axons was measured in micrometers using the IBAS image analysis system. There was a strong, positive and significant relationship between the mean size of axonal swelling and survival time which plateaued at around 85 h post injury. With longer survival times the situation becomes more complex. betaAPP immunolabelling of damaged axons can contribute evidence about trauma and post-injury survival time in the forensic setting but should always be assessed with other evidence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442560     DOI: 10.1007/s004010051069

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Induction of Diffuse Axonal Brain Injury in Rats Based on Rotational Acceleration.

Authors:  Dmitry Frank; Israel Melamed; Benjamin F Gruenbaum; Julia Grinshpun; Ruslan Kuts; Rachel Shvartsur; Abed N Azab; Mohamad H Assadi; Max Vinokur; Matthew Boyko
Journal:  J Vis Exp       Date:  2020-05-09       Impact factor: 1.355

Review 2.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

3.  Regional neurodegeneration and gliosis are amplified by mild traumatic brain injury repeated at 24-hour intervals.

Authors:  Amanda N Bolton; Kathryn E Saatman
Journal:  J Neuropathol Exp Neurol       Date:  2014-10       Impact factor: 3.685

Review 4.  Traumatic axonal injury: neuropathological features, postmortem diagnostic methods, and strategies.

Authors:  Qianling Chen; Xuebing Chen; Luyao Xu; Rui Zhang; Zhigang Li; Xia Yue; Dongfang Qiao
Journal:  Forensic Sci Med Pathol       Date:  2022-09-19       Impact factor: 2.456

5.  Repeated traumatic brain injury affects composite cognitive function in piglets.

Authors:  Stuart H Friess; Rebecca N Ichord; Jill Ralston; Karen Ryall; Mark A Helfaer; Colin Smith; Susan S Margulies
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

6.  PATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASES.

Authors:  Xin-An Liu; Valerio Rizzo; Sathyanarayanan V Puthanveettil
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

7.  Mapping mean axon diameter and axonal volume fraction by MRI using temporal diffusion spectroscopy.

Authors:  Junzhong Xu; Hua Li; Kevin D Harkins; Xiaoyu Jiang; Jingping Xie; Hakmook Kang; Mark D Does; John C Gore
Journal:  Neuroimage       Date:  2014-09-16       Impact factor: 6.556

8.  Fast and simplified mapping of mean axon diameter using temporal diffusion spectroscopy.

Authors:  Junzhong Xu; Hua Li; Ke Li; Kevin D Harkins; Xiaoyu Jiang; Jingping Xie; Hakmook Kang; Richard D Dortch; Adam W Anderson; Mark D Does; John C Gore
Journal:  NMR Biomed       Date:  2016-01-19       Impact factor: 4.044

9.  Modeling diffusion of intracellular metabolites in the mouse brain up to very high diffusion-weighting: Diffusion in long fibers (almost) accounts for non-monoexponential attenuation.

Authors:  Marco Palombo; Clemence Ligneul; Julien Valette
Journal:  Magn Reson Med       Date:  2016-11-07       Impact factor: 4.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.